Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

IOWA PHYSICIANS CLINIC MEDICAL FOUNDATION

NPI: 1538617840 · CEDAR FALLS, IA 50613 · Clinical Medical Laboratory · NPI assigned 09/15/2016

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WILLIAMS, DAVID controls 20+ related entities in our dataset. Read more

$987K
Total Medicaid Paid
93,224
Total Claims
87,844
Beneficiaries
79
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialWILLIAMS, DAVID (PRESIDENT/CEO)
Parent OrganizationIOWA PHYSICIANS CLINIC MEDICAL FOUNDATION
NPI Enumeration Date09/15/2016

Related Entities

Other providers sharing the same authorized official: WILLIAMS, DAVID

ProviderCityStateTotal Paid
MEDFAST URGENT CARE CENTERS LLC MELBOURNE FL $6.26M
RAPIDES HEALTHCARE SYSTEM, LLC ALEXANDRIA LA $1.28M
LIFE SERVICES INC. NORTH CHESTERFIELD VA $1.16M
IOWA PHYSICIANS CLINIC MEDICAL FOUNDATION MUSCATINE IA $839K
TEXAN ANESTHESIOLOGY ASSOCIATION, PA AUSTIN TX $838K
IOWA PHYSICIANS CLINIC MEDICAL FOUNDATION FORT DODGE IA $828K
IOWA PHYSICIANS CLINIC MEDICAL FOUNDATION CHILLICOTHE IL $727K
IOWA PHYSICIANS CLINIC MEDICAL FOUNDATION PRINCEVILLE IL $670K
IOWA PHYSICIANS CLINIC MEDICAL FOUNDATION GENESEO IL $566K
ALLEN COUNTY HEALTH DEPARTMENT SCOTTSVILLE KY $548K
IOWA PHYSICIANS CLINIC MEDICAL FOUNDATION MUSCATINE IA $507K
ALLEN COUNTY HEALTH DEPARTMENT SCOTTSVILLE KY $494K
IOWA PHYSICIANS CLINIC MEDICAL FOUNDATION MUSCATINE IA $403K
IOWA PHYSICIANS CLINIC MEDICAL FOUNDATION MUSCATINE IA $335K
ALLEN COUNTY HEALTH DEPT SCOTTSVILLE KY $277K
ALLEN COUNTY HEALTH DEPARTMENT SCOTTSVILLE KY $263K
IOWA PHYSICIANS CLINIC MEDICAL FOUNDATION LACON IL $238K
ALLEN COUNTY HEALTH DEPARTMENT SCOTTSVILLE KY $225K
IOWA PHYSICIANS CLINIC MEDICAL FOUNDATION WILTON IA $154K
COMMUNITY STRONG COUNSELING LLC LAWTON OK $100K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 11,673 $133K
2019 13,441 $160K
2020 12,501 $145K
2021 16,869 $176K
2022 19,606 $211K
2023 13,520 $125K
2024 5,614 $37K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
36415 Collection of venous blood by venipuncture 23,494 21,829 $90K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 2,339 2,145 $74K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2,339 2,143 $74K
84443 Thyroid stimulating hormone (TSH) 5,148 4,907 $74K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2,088 2,014 $52K
80061 Lipid panel 3,699 3,564 $42K
80048 Basic metabolic panel (calcium, ionized) 4,955 4,722 $36K
83036 Hemoglobin; glycosylated (A1C) 4,343 4,200 $35K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 4,774 4,577 $32K
87660 1,521 1,461 $28K
87510 1,519 1,460 $28K
87480 1,519 1,460 $28K
80050 General health panel 683 574 $28K
80053 Comprehensive metabolic panel 2,948 2,809 $27K
85027 4,526 4,359 $26K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 211 193 $26K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 637 606 $23K
84439 2,997 2,843 $23K
83655 1,821 1,788 $21K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 156 148 $20K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1,103 993 $19K
84480 1,154 1,095 $14K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 313 299 $13K
87086 Culture, bacterial; quantitative colony count, urine 1,681 1,536 $11K
84403 412 401 $10K
82728 807 779 $9K
84702 720 605 $8K
80076 984 946 $7K
82746 542 517 $6K
81002 2,106 1,789 $6K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 15 14 $6K
0240U 44 42 $5K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 74 73 $5K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 200 184 $5K
83550 720 694 $5K
85018 2,011 1,997 $5K
83540 830 797 $5K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 35 32 $4K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 45 42 $4K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 245 235 $3K
82570 813 779 $3K
82043 684 664 $3K
80306 212 201 $3K
85651 849 807 $3K
82607 255 240 $3K
81025 361 348 $3K
80305 279 208 $3K
86780 206 191 $2K
86140 469 451 $2K
86762 191 167 $2K
87340 312 267 $2K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 75 74 $2K
81001 603 576 $2K
86756 100 95 $2K
82677 86 80 $2K
87653 47 41 $1K
86592 403 348 $1K
82105 99 92 $1K
86336 86 80 $975.44
82950 217 203 $877.71
80074 12 12 $543.00
87581 15 14 $499.88
87486 15 14 $499.88
84163 33 29 $399.66
84460 88 80 $364.35
87070 38 34 $357.02
84450 87 79 $350.75
87186 15 13 $155.52
86803 14 13 $149.16
81003 76 72 $141.58
87077 15 13 $132.70
87081 14 14 $106.96
83690 13 12 $77.31
86431 12 12 $59.29
3044F 509 488 $0.00
0064U 45 45 $0.00
3052F 13 12 $0.00
3051F 56 55 $0.00
3046F 49 49 $0.00